|
To: Maine Immunization Program Providers
From: Maine Immunization Program
Subject: Novavax Booster Authorization
Date: October 20, 2022
The CDC’s Advisory Committee on Immunization Practices’ (ACIP) has now authorized the Novavax monovalent COVID-19 boosters for to be administered to people ages 18 years and older targeting the original COVID-19 strain. This recommendation followed the FDA’s granting of emergency use authorization.
The Novavax monovalent COVID-19 boosters may be given to adults if they:
- are 18 years or older,
- have completed a primary series vaccination,
- have not previously received a COVID-19 booster and,
- cannot or will not receive an updated mRNA booster.
The Novavax COVID-19 vaccine booster is a 0.5 mL dose and may be administered at least 6 months after completion of primary vaccination with an authorized or approved COVID-19 vaccine.
Resources
Below is a list of resources and upcoming informational activities related to the recommendations.
- Web resources for immunization partners:
If you have any questions, please contact the Maine Immunization Program at (207) 287-3746 or email: ImmunizeME.DHHS@maine.gov.
Thank you for your continued efforts to ensure that all Mainers have access to COVID-19 vaccination.
|
